Developing the vaccines
of the future
VLPbio provides first-class technology for the development of biotechnology-based vaccines in the animal health field, with highly improved properties
Our portfolio already contains products against most critical diseases in the veterinary field, targeting a global market of more than 1.5 billion euros
The experienced team at VLPbio understands R&D management as a business, with the unique purpose of speeding-up and de-risking product development
We develop new vaccines against most serious animal diseases
Several entities recognize and believe in the potential of VLPbio technology, and support our different projects
